Fulgent Genetics, Inc. FLGT Long-term marketable securities
Long-term marketable securities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s long-term marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s long-term marketable securities?
- Fulgent Genetics, Inc. (FLGT) reported long-term marketable securities of $328.29M in Q1 2026.
- How has Fulgent Genetics, Inc.'s long-term marketable securities changed year-over-year?
- Fulgent Genetics, Inc.'s long-term marketable securities decreased by 33.6% year-over-year, from $494.11M to $328.29M.
- What is the long-term trend for Fulgent Genetics, Inc.'s long-term marketable securities?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s long-term marketable securities has grown at a 22.8% compound annual growth rate (CAGR), from $132.5M to $369.27M.